South Korea Hydrophobic Interaction Chromatography Market Research Report: By Product and Service (Resins, Columns, Services, Others)- Forecast to 2035
ID: MRFR/HC/54728-HCR | 200 Pages | Author: Garvit Vyas| June 2025
As per MRFR analysis, the South Korea Hydrophobic Interaction Chromatography Market Size was estimated at 3.22 (USD Million) in 2023.The South Korea Hydrophobic Interaction Chromatography Market Industry is expected to grow from 4.5(USD Million) in 2024 to 10.2 (USD Million) by 2035. The South Korea Hydrophobic Interaction Chromatography Market CAGR (growth rate) is expected to be around 7.723% during the forecast period (2025 - 2035).
Research and development activities within the biopharmaceutical industry are continuously rising, resulting in the rapid expansion of South Korea’s Hydrophobic Interaction Chromatography market. Institutions and companies are focusing on automated therapeutic protein purification and monoclonal antibody production, which require sophisticated chromatographic methods, advanced automation, and artificial intelligence capabilities. Government subsidies and policies promoting the biotechnology industry also have a positive impact on the market, as biotechnologies are crucial for South Korea’s economic growth. The development of new HIC materials and technologies that are more affordable and efficient, tailored to South Korean laboratories that lead in biomanufacturing innovation, is one potential area of opportunity for market participants.
There is a focus on automating and integrating HIC and other chromatographic systems, leading to increased reproducibility and process optimization by South Korean researchers and QC labs. Industrial-academic collaboration is on the rise, which means that there are various educational schemes aimed at increasing the number of skilled professionals able to apply HIC methods in the region. The constant evolution of analytical tools and data management technologies creates new opportunities for better integration and analysis of data in bioprocessing systems. On the other hand, there is a growing focus on sustainable hydrophobic interaction chromatography, which is increasing investment in green materials and processes.
To stay relevant in the moving market of South Korea, it will be important for manufacturers to adopt the new changes in trends and fulfill the requirements of the biotechnology industry.
The South Korea Hydrophobic Interaction Chromatography Market Industry is expected to experience significant growth due to the increasing production of biopharmaceuticals. South Korea is emerging as a major hub for biopharmaceutical manufacturing, with a focus on biologics and biosimilars. The Korean Ministry of Health and Welfare reported that the country produced over 80% of its biopharmaceuticals locally in recent years, leading to an impressive annual growth rate of around 10% in this sector.This growth is further supported by large pharmaceutical companies like Samsung Biologics and SK Biopharmaceuticals, which are investing heavily in advanced manufacturing technologies, including hydrophobic interaction chromatography techniques. The rising demand for monoclonal antibodies and other therapeutic proteins necessitates efficient purification technologies, propelling the demand for hydrophobic interaction chromatography applications in bioprocessing and downstream operations.
The South Korea Hydrophobic Interaction Chromatography Market Industry is being driven by a strong emphasis on Research and Development (R&D) activities within the biopharmaceutical sector. The South Korean government has set ambitious R&D investment targets, allocating approximately 4.5% of its GDP towards R&D initiatives, significantly higher than the global average of 2.5%. This increase in funding supports academic institutions and private laboratories in developing better purification methods using hydrophobic interaction chromatography, facilitating breakthroughs in biological product development.Institutions like POSTECH, which focuses on biochemistry and biotechnology, are significantly advancing knowledge in this area. As a result, more sophisticated separation technologies are being developed, thereby necessitating the adoption of hydrophobic interaction chromatography for effective and high-yield biopharmaceutical production.
The South Korea Hydrophobic Interaction Chromatography Market Industry is also being bolstered by the rising incidence of chronic diseases. According to the Ministry of Health and Welfare, the prevalence of chronic diseases in South Korea has surged over the past decade, with reports indicating that approximately 45% of the population is living with at least one chronic condition. This rise has led to an increasing demand for innovative treatment solutions, including biopharmaceuticals.Given that many chronic conditions require therapeutic proteins for effective treatment, the utilization of hydrophobic interaction chromatography will be crucial for the efficient purification of these products. Companies like LG Chem are focusing on developing new biologics to cater to this growing market, further driving the implementation of hydrophobic interaction chromatography in the production process.
The South Korea Hydrophobic Interaction Chromatography Market is experiencing significant growth, particularly in the Product and Service segment, which encompasses various crucial components such as Resins, Columns, Services, and Others. With the increasing application of biomolecules in drug development and the rise in Research and Development activities within the pharmaceutical sector, Resins have become a vital element, offering efficient separation and purification processes that are essential for biopharmaceutical products.
Similarly, Columns play an important role in enhancing the performance and efficiency of hydrophobic interaction chromatography, ensuring greater throughput and resolution in analytical and preparative applications.As the demand for advanced bioprocessing solutions grows, the involvement of Services tied to hydrophobic interaction chromatography is also substantial, providing necessary technical support, training, and maintenance services that enhance the operational efficiencies for laboratories and industrial facilities.
Additionally, the Others category encompasses various ancillary products and innovations that contribute to the overall functioning and effectiveness of chromatography systems, reflecting the diversity of offerings within this segment.The prominence of the South Korea Hydrophobic Interaction Chromatography Market stems from a robust biopharmaceutical industry bolstered by government initiatives and investments in biotechnology, thereby solidifying its position in the global market. As organizations continue to focus on developing more effective therapeutic solutions, the significance of hydrophobic interaction chromatography technologies for drug purification and characterization is poised to increase markedly in South Korea, driven by this innovation-focused environment and the ongoing surge in scientific research.
The South Korea Hydrophobic Interaction Chromatography Market is characterized by a dynamic competitive landscape, driven largely by the growing demand for protein purification and biopharmaceutical production. Hydrophobic interaction chromatography, known for its ability to separate biomolecules based on hydrophobicity, has garnered significant interest within the biotechnological and pharmaceutical sectors in South Korea. This region's robust investment in research and development, along with advances in bioprocessing technologies, is fostering an environment conducive to the proliferation of innovative chromatographic techniques.
As companies vie for market share, it is essential to analyze their strategic positioning, product offerings, and overall market strategies to gain insights into current trends and future opportunities within this specialized segment.Agilent Technologies has made a substantial impact in the South Korea Hydrophobic Interaction Chromatography Market, known for its cutting-edge technologies and strong product portfolio. The company boasts an extensive range of chromatography systems and columns tailored to meet the unique requirements of protein separations. Agilent's commitment to quality and innovation has positioned it as a trusted partner for various research institutions and biopharmaceutical firms in South Korea. With its robust support infrastructure, comprehensive customer service, and a solid reputation for reliability, Agilent Technologies has successfully established a strong presence in the market, enabling scientists and researchers to optimize their workflows and enhance productivity in protein research and purification applications.
Cytiva, known for its dedication to advancing the field of bioprocessing, has also established a notable footprint in the South Korea Hydrophobic Interaction Chromatography Market. The company offers a wide range of key products, including its prepacked chromatography columns and media designed specifically for protein purification. Cytiva’s strengths lie in its innovation-driven approach, evidenced by its ongoing investments in research and development within the South Korean market. The company has engaged in strategic partnerships and collaborations that enhance its market positioning, reinforcing its commitment to supporting biopharmaceutical production processes. Additionally, Cytiva has expanded its offerings through strategic mergers and acquisitions, allowing it to combine advanced technologies and expand its product range, thus providing more comprehensive solutions to its customers in South Korea's biopharmaceutical industry.
Significant developments are currently shaping the South Korea Hydrophobic Interaction Chromatography Market, with major companies like Agilent Technologies, Cytiva, and Waters Corporation actively expanding their portfolio and technologies in this sector. The market has seen a notable demand surge due to increasing biopharmaceutical investments, specifically in protein purification and analysis. In recent months, Merck KGaA has announced plans to enhance its offerings in chromatographic solutions, reflecting the ongoing growth trajectory in the industry as presented in the South Korean government reports highlighting advancements in biomanufacturing. Moreover, the market is witnessing increased collaboration and innovation among leading entities.
In a notable move, Thermo Fisher Scientific announced an acquisition in July 2023 aimed at strengthening its capabilities in the chromatography sector. Additionally, growth in market valuation is evident, with companies like Repligen Corporation and Sartorius AG reporting substantial increases in their market share and revenue in the last two years, driven by the expanding scope of hydrophobic interaction chromatography applications in drug development and clinical research. Overall, the South Korean Hydrophobic Interaction Chromatography Market is experiencing significant growth spurred by advancements and strategic initiatives from key players.
Report Scope:
Report Attribute/Metric Source: | Details |
MARKET SIZE 2018 | 3.22(USD Million) |
MARKET SIZE 2024 | 4.5(USD Million) |
MARKET SIZE 2035 | 10.2(USD Million) |
COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.723% (2025 - 2035) |
REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
BASE YEAR | 2024 |
MARKET FORECAST PERIOD | 2025 - 2035 |
HISTORICAL DATA | 2019 - 2024 |
MARKET FORECAST UNITS | USD Million |
KEY COMPANIES PROFILED | Agilent Technologies, Cytiva, Repligen Corporation, Hitachi HighTechnologies, Merck KGaA, Waters Corporation, Sartorius AG, Pall Corporation, Emerson Electric, BioRad Laboratories, Boehringer Ingelheim, Thermo Fisher Scientific, MilliporeSigma, Tosoh Corporation, GE Healthcare |
SEGMENTS COVERED | Product and Service |
KEY MARKET OPPORTUNITIES | Rising biopharmaceutical production demand, Growing investment in R&D, Expanding biotechnology sector, Increasing adoption of automation, Enhanced focus on process optimization |
KEY MARKET DYNAMICS | growing biopharmaceutical industry, increasing R&D investments, demand for purification technologies, advancements in chromatography techniques, rise in biologics production |
COUNTRIES COVERED | South Korea |
Frequently Asked Questions (FAQ) :
The South Korea Hydrophobic Interaction Chromatography Market is expected to be valued at 4.5 million USD in 2024.
By 2035, the South Korea Hydrophobic Interaction Chromatography Market is projected to reach a value of 10.2 million USD.
The expected compound annual growth rate (CAGR) for the market from 2025 to 2035 is 7.723%.
In 2035, the Resins segment is expected to have the highest market value at 4.1 million USD.
Major players in the market include Agilent Technologies, Cytiva, Repligen Corporation, and Merck KGaA.
The Columns segment is estimated to be valued at 1.2 million USD in 2024.
The Services segment is projected to be worth 3.4 million USD in 2035.
The market faces challenges such as technological advancements and the need for innovation to remain competitive.
Opportunities for growth include expansion in biopharmaceutical applications and increased demand for innovative chromatography solutions.
Regional dynamics significantly influence market growth patterns and competitive strategies among key players in South Korea.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)